Cargando…

Using health technology assessment to inform insurance reimbursement of high technology medicines in China: an example of cancer immunotherapy

Yingyao Chen and colleagues examine what can be learnt from China’s approach to funding expensive high technology medicines with uncertain long term benefit

Detalles Bibliográficos
Autores principales:	Chen, Yingyao, Dong, Hengjin, Wei, Yan, Yang, Yi, Ming, Jian, Yu, Hao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group Ltd. 2023
Materias:	Analysis
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10266439/ https://www.ncbi.nlm.nih.gov/pubmed/37321628 http://dx.doi.org/10.1136/bmj-2022-069963

Ejemplares similares

Use of health technology assessment in drug reimbursement decisions in China
por: Chen, Wen, et al.
Publicado: (2023)

Health technology assessment to inform decision making in China: progress, challenges, and sustainability
por: Chen, Yingyao, et al.
Publicado: (2023)

How health technology reassessment can support disinvestment in China’s national drug reimbursement list
por: Shi, Lizheng, et al.
Publicado: (2023)

Using economic evaluations to support acupuncture reimbursement decisions: current evidence and gaps
por: Li, Hongchao, et al.
Publicado: (2022)

Use of health technology assessment in drug reimbursement decisions in China
Publicado: (2023)

Determinants of knowledge translation from health technology assessment to policy-making in China: From the perspective of researchers
por: Liu, Wenbin, et al.
Publicado: (2018)

Institutionalising health technology assessment: establishing the Medical Technology Assessment Board in India
por: Downey, Laura E, et al.
Publicado: (2017)

Health technology assessment and economic evaluation: Is it applicable for the traditional medicine?
por: Chen, Yingyao
Publicado: (2022)

Using information technology to improve surveillance of antimicrobial resistance in South East Asia
por: Vong, Sirenda, et al.
Publicado: (2017)

Reporting quality of economic evaluations of the negotiated Traditional Chinese Medicines in national reimbursement drug list of China: A systematic review
por: Yan, Juntao, et al.
Publicado: (2023)

Reimbursement of pharmaceuticals: reference pricing versus health technology assessment
por: Drummond, Michael, et al.
Publicado: (2010)

Enhancing financial protection under China’s social health insurance to achieve universal health coverage
por: Fang, Hai, et al.
Publicado: (2019)

Cancer therapy: reimbursement of new therapeutic technologies.
por: Williams, H. M.
Publicado: (1992)

Drug pricing and reimbursement decision making systems in Mongolia
por: Dorj, Gereltuya, et al.
Publicado: (2017)

Physician pricing and health insurance reimbursement
por: Yett, Donald E., et al.
Publicado: (1983)

Assessment and evaluation of information technologies in medicine
por: Gennip, EMSJ van, et al.
Publicado: (1995)

Evidence for the effectiveness of anti-hypertensive medicines included on the Chinese National Reimbursement Drug List
por: Liu, Wenbin, et al.
Publicado: (2019)

Social health insurance for the poor: lessons from a health insurance programme in Karnataka, India
por: Sood, Neeraj, et al.
Publicado: (2018)

Regarding: “Insurance Reimbursement for Complementary Healthcare Services”
por: Whedon, James M.
Publicado: (2018)

Health Insurance Claim Review Using Information Technologies
por: Park, Young-Taek, et al.
Publicado: (2012)

Effects of Health Information Technology on Malpractice Insurance Premiums
por: Kim, Hye Yeong, et al.
Publicado: (2015)

Health technology assessment and reimbursement policy for oncology orphan drugs in Central and Eastern Europe
por: Malinowski, Krzysztof Piotr, et al.
Publicado: (2020)

Were economic evaluations well reported for the newly listed oncology drugs in China’s national reimbursement drug list
por: Liu, Liu, et al.
Publicado: (2022)

Information technologies in medicine
por: Akay, Metin, et al.
Publicado: (2001)

Telemedicine technologies: information technologies in medicine and telehealth
por: Fong, Bernard, et al.
Publicado: (2010)

Comparing Maternal Services Utilization and Expense Reimbursement before and after the Adjustment of the New Rural Cooperative Medical Scheme Policy in Rural China
por: You, Hua, et al.
Publicado: (2016)

Digital adherence technologies for the management of tuberculosis therapy: mapping the landscape and research priorities
por: Subbaraman, Ramnath, et al.
Publicado: (2018)

Connecting the dots: Kerala’s use of digital technology during the COVID-19 response
por: Ummer, Osama, et al.
Publicado: (2021)

Reimbursement of Orphan Drugs in Europe in Relation to the Type of Authorization by the European Medicines Agency and the Decision Making Based on Health Technology Assessment
por: Malinowski, Krzysztof Piotr, et al.
Publicado: (2018)

Characteristics and implications of insurance-reimbursed inpatient care for gastric and oesophageal cancers in Anhui, China
por: Yao, Anqi, et al.
Publicado: (2020)

Correction: Comparing Maternal Services Utilization and Expense Reimbursement Before and After the Adjustment of the New Rural Cooperative Medical Scheme Policy in Rural China
por: You, Hua, et al.
Publicado: (2017)

Close cooperation with Health Technology Assessment expertise is crucial for implementation and ultimately reimbursement of innovations in oncology
por: van Harten, WH, et al.
Publicado: (2016)

Conflict of interest in Health Technology Assessment decisions: case law in France and impact on reimbursement decisions
por: Frybourg, Sandrine, et al.
Publicado: (2015)

Description of the use of multicriteria to support pricing and reimbursement decisions by European health technology assessment bodies
por: Elvira, David, et al.
Publicado: (2021)

Correction: Effects of Health Information Technology on Malpractice Insurance Premiums
por: Kim, Hye Yeong, et al.
Publicado: (2015)

From blockchain technology to global health equity: can cryptocurrencies finance universal health coverage?
por: Till, Brian M, et al.
Publicado: (2017)

Telemedicine technologies: information technologies in medicine and digital health
por: Fong, Bernard, et al.
Publicado: (2020)

Weak surveillance and policy attention to cancer in global health: the example of Mozambique
por: Lorenzoni, Cesaltina, et al.
Publicado: (2018)

The Sustainable Development Goals and Technological Capacity
por: Mayer-Foulkes, David, et al.
Publicado: (2021)

Use of Patient Preference Information in Benefit–Risk Assessment, Health Technology Assessment, and Pricing and Reimbursement Decisions: A Systematic Literature Review of Attempts and Initiatives
por: Chachoua, Lylia, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_qhr7uqj4vuueqeqo96m2tko6t1